JPRN-UMIN000012330已完成未知
A prospective, randomized, open-label parallel-group clinical study to investigate effects and maneuverability of device of fluticasone/formoterol pMDI (Flutiform) vs. fluticasone/salmeterol DPI (Adoair Diskus) in patients who have poorly controlled asthma - Study on the efficacy of a fixed-dose combination of fluticasone propionate and formoterol fumarate hydrate (Flutiform)
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 24
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •(1) Patients who have experienced adverse drug reactions caused by treatment with an ICS, LABA, or concomitant use or a combination of ICS and LABA (2) Patients with severe cardiac, hepatic, renal, pulmonary, or hematologic disease (3) Patients with complications of apparent chronic obstructive pulmonary disease (COPD) (4) Patients with complications of malignant tumors (5) Patients with a history of smoking within the past 1 year (6) Patients who are pregnant, lactating, or desire to conceive during the study period (7) Patients who were judged unsuitable for enrollment in the study by the investigator or the sub-investigator
研究者
相似试验
已完成
不适用
A prospective, randomized, open-label parallel-group clinical study to investigate effects of fluticasone/formoterol pMDI (Flutiform) vs fluticasone/salmeterol DPI (Adoair Diskus) in asthmatic patients with small airway inflammatioBronchial asthmaJPRN-UMIN000012331KYORIN Pharmaceutical Co., Ltd.32
已完成
不适用
A prospective, randomized, open-label parallel-group clinical study to investigate effects and maneuverability of devices of fluticasone/formoterol pMDI (Flutiform) vs. fluticasone/salmeterol DPI (Adoair Diskus) in patients who have poorly controlled asthmaBronchial asthmaJPRN-UMIN000012327KYORIN Pharmaceutical Co., Ltd.21
已完成
不适用
A prospective, randomized, open-label parallel-group clinical study to investigate effects of fluticasone/formoterol pMDI (Flutiform) vs fluticasone/salmeterol DPI (Adoair Diskus) or pMDI (Adoair Aerosol) in asthmatic patients with small airway inflammatioBronchial asthmaJPRN-UMIN000012332KYORIN Pharmaceutical Co., Ltd.40
进行中（未招募）
不适用
Explore the efficacy and safety of once-daily oral rivaroxaban for the prevention of cardiovascular events in subjects with nonvalvular atrial fibrillation scheduled for cardioversioEUCTR2011-002234-39-ITBAYER HEALTHCARE AG1,500
进行中（未招募）
不适用
Explore the efficacy and safety of once-daily oral rivaroxaban for the prevention of cardiovascular events in subjects with nonvalvular atrial fibrillation scheduled for cardioversioprevention of stroke and non-central nervous system systemic embolism in subjects with non-valvular atrial fibrillation scheduled for cardioversionMedDRA version: 14.1Level: PTClassification code 10003658Term: Atrial fibrillationSystem Organ Class: 10007541 - Cardiac disordersEUCTR2011-002234-39-DKBayer HealthCare AG1,500